FFA
JANX icon

Farther Finance Advisors’s Janux Therapeutics JANX Stock Holding History

Farther Finance Advisors’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.61K Buy
209
+46
+28% +$773 ﹤0.01% 5169
2026
Q2 		$2.5K Buy
163
+18
+12% +$261 ﹤0.01% 5094
2026
Q1 		$2.1K Buy
+145
New +$1.99K ﹤0.01% 4884

Other funds holding JANX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's JANX Position: Q3 2026 in Review

Farther Finance Advisors increased its Janux Therapeutics (JANX) stake by 28% in Q3 2026, buying an estimated $773 and bringing the position to 209 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #5169.

Farther Finance Advisors first reported a position in JANX in Q1 2026 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • Farther Finance Advisors held 209 shares of Janux Therapeutics worth $3.61K as of Q3 2026.
  • Farther Finance Advisors bought 46 Janux Therapeutics shares in Q3 2026, an estimated $773.
  • Janux Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5169 holding.
  • Farther Finance Advisors first reported a position in Janux Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 6 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.